{
    "data": [
        {
            "id": "6903645aecb8a70001457d8e",
            "title": "Takeda Lowers 2025 Outlook After Weak Q2 And Pipeline Impairment Charges",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Takeda Pharmaceutical Company Limited</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TAK\" target=\"_blank\">TAK</a>) posted a <a href=\"https://www.benzinga.com/pressreleases/25/10/b48518776/takeda-reports-first-half-fy2025-results-with-business-fundamentals-tracking-as-planned-updates-fu\" rel=\"noreferrer noopener\" target=\"_blank\">second-quarter 2025 </a>adjusted net profit of 201.6 billion Japanese yen (approximately $1.31 billion).</p><!--/$--><!--$--><p class=\"block core-block\">The company reported earnings per American Depositary Share (EPADS) of 43 cents, missing analyst <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">expectations of 44 cents</a>. However, in yen, earnings per share declined 4.5% to 128 yen.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Total sales for the quarter amounted to $7.52 billion (1.18 trillion yen), missing the consensus estimates of $8.08 billion.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/news/health-care/25/10/48209315/takeda-taps-nabla-bios-generative-ai-platform-for-antibody-design-in-1-billion-pact\" rel=\"noreferrer noopener\" target=\"_blank\">Takeda Taps Nabla Bio’s Generative AI Platform For Antibody Design In $1 Billion Pact</a></strong></p><!--/$--><!--$--><p class=\"block core-block\">\"Takeda's fiscal year 2025 first half results are consistent with our expectations for core business progress in this year of transition to a new phase focusing on new product launches. Our updated full-year outlook reflects impairment charges associated with strategic pipeline decisions taken in Q2 and transactional FX…,” Takeda CEO <strong>Christophe Weber</strong> said.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">First half 2025 sales fell 6.9% (-3.9% at constant currency) to 2.22 trillion yen, while core operating profit slumped 11.2% to 639.2 billion yen.</p><!--/$--><!--$--><p class=\"block core-block\">The decline was primarily due to a decrease in Neuroscience revenue, mainly from the continued impact of generic erosion of Vyvanse for attention deficit hyperactivity disorder (ADHD).</p><!--/$--><!--$--><p class=\"block core-block\">Second quarter Neuroscience <a href=\"https://assets-dam.takeda.com/image/upload/v1761806490/Global/Investor/Financial-Results/FY2025/Q2/qr2025_q2_qfr_en.pdf\" rel=\"noreferrer noopener\" target=\"_blank\">sales</a> fell 33% to 97.5 billion yen, vaccine sales were down 21.1% to 20.2 billion yen, and cancer drug sales were up 4.3% to 149.1 billion yen.</p><!--/$--><!--$--><p class=\"block core-block\">Gastrointestinal sales rose 2% to 353.5 billion yen, while rare diseases revenue fell 2.7% to 184.1 billion yen.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Outlook</strong></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Takeda has <a href=\"https://assets-dam.takeda.com/image/upload/v1761806800/Global/Investor/Financial-Results/FY2025/Q2/FY2025_Q2_Press_Release_1030.pdf\" rel=\"noreferrer noopener\" target=\"_blank\">updated</a> its full-year 2025 outlook to reflect foreign exchange impacts and impairment charges related to the cell therapy platform.</p><!--/$--><!--$--><p class=\"block core-block\">Takeda revised its core revenue guidance from 4.53 trillion yen to 4.50 trillion yen.</p><!--/$--><!--$--><p class=\"block core-block\">The Japanese drug maker expects core operating profit of 1.13 trillion yen<span style=\"box-sizing:border-box;margin:0px;padding:0px\">, <a href=\"https://www.benzinga.com/markets/earnings/25/07/46737233/takeda-pharma-maintains-outlook-even-as-vyvanse-generics-hit-sales\" rel=\"noopener\" target=\"_blank\">down from prior guidance</a> of 1.14 trillion yen, and core earnings of 479 yen, </span>down from previous guidance of 485 yen.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> TAK stock is trading 2.25% lower at $13.46 in the premarket at the last check on Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48526401\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/news/health-care/25/10/48486716/trump-administration-move-could-put-medical-debt-back-on-us-credit-reports-experts-warn-of-chilling-effect\" rel=\"noreferrer noopener\" target=\"_blank\">Trump Administration Move Could Put Medical Debt Back On US Credit Reports, Experts Warn Of ‘Chilling Effect’</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Takeda-Pharmaceutical-Company.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48526401/takeda-lowers-2025-outlook-after-weak-q2-and-pipeline-impairment-charges",
            "pub_date": "2025-10-30 21:13:01",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690366c7ecb8a70001457eb0",
            "title": "XPO Surpasses Q3 Earnings Expectations, CEO Says NA Segment &#39;Outperforms Seasonality&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>XPO, Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/XPO\" target=\"_blank\">XPO</a>) shares are trading higher premarket on Thursday after the company reported <a href=\"https://www.benzinga.com/pressreleases/25/10/g48521973/xpo-reports-third-quarter-2025-results\" rel=\"noreferrer noopener\" target=\"_blank\">third-quarter 2025 financial results</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Details</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Revenue reached $2.11 billion for the quarter, surpassing estimates of $2.07 billion.</p><!--/$--><!--$--><p class=\"block core-block\">On an adjusted basis, net income was $128 million for the quarter, compared to $122 million in the third quarter of 2024. Adjusted EPS of $1.07 exceeded <a href=\"https://www.benzinga.com/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">the analyst consensus of $1.02</a>.</p><!--/$--><!--$--><p class=\"block core-block\">XPO's operating income declined to $164 million from $176 million in the same period last year.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: </em></strong><em><a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48056036/trucking-company-stocks-are-climbing-monday-whats-driving-the-rally\" rel=\"noreferrer noopener\" target=\"_blank\">Trucking Company Stocks Are Climbing: What’s Driving The Rally?</a></em></p><!--/$--><!--$--><p class=\"block core-block\">Adjusted EBITDA for the third quarter was $342 million, an increase from $333 million in the prior year.</p><!--/$--><!--$--><p class=\"block core-block\">XPO generated $371 million in operating cash flow and ended the quarter with $335 million in cash and cash equivalents.</p><!--/$--><!--$--><p class=\"block core-block\">The company repurchased $50 million of shares in the third quarter. </p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><p class=\"block core-block\">XPO's North American Less-Than-Truckload (LTL) segment revenue stood at $1.26 billion, a 0.3% increase year over year (Y/Y), attributed to a 3.5% Y/Y decline in shipments per day and a 6.1% Y/Y drop in tonnage per day.</p><!--/$--><!--$--><p class=\"block core-block\">LTL segment achieved an adjusted operating ratio of 82.7%, a 150-basis-point improvement year-over-year, which CEO <strong>Mario Harik</strong> referred to as \"significantly outperforming seasonality.\"</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Yield, excluding fuel, increased by 5.9% Y/Y, and revenue per shipment (excluding fuel surcharges) grew by 3.4% Y/Y in the quarter.</p><!--/$--><!--$--><p class=\"block core-block\">Adjusted EBITDA for the North American LTL segment increased 8.5% Y/Y to $308 million in the quarter.</p><!--/$--><!--$--><p class=\"block core-block\">Meanwhile, the European Transportation segment reported revenue of $857 million, up 6.7% Y/Y. However, adjusted EBITDA for this segment declined to $38 million from $44 million in the prior year.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> XPO shares are up 1.60% to $126.75 in premarket trading at the last check on Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48526681\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/node/48496887\" rel=\"noreferrer noopener\" target=\"_blank\">ODFL Shares Jump As Q3 Earnings Top Forecasts Despite Freight Slowdown</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/XPO--Inc.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48526681/xpo-surpasses-q3-earnings-expectations-ceo-says-na-segment-outperforms-seasonality",
            "pub_date": "2025-10-30 21:23:23",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69035d2decb8a70001457954",
            "title": "Kimberly-Clark Proves Resilient With Firm Sales In Shifting Market",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Kimberly-Clark Corporation</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/KMB\" target=\"_blank\">KMB</a>) shares were trading higher in the premarket session on Thursday after the company <a href=\"https://www.benzinga.com/pressreleases/25/10/n48521515/kimberly-clark-announces-third-quarter-2025-results-updates-2025-outlook\" rel=\"noreferrer noopener\" target=\"_blank\">reported third-quarter fiscal 2025 results</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Key Figures</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings per share of $1.82, beating the analyst consensus estimate of $1.76.</p><!--/$--><!--$--><p class=\"block core-block\">Quarterly sales of $4.15 billion, flat year over year (Y/Y), surpassed the street view of $4.12 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Sales reflect a 2.2% headwind from the U.S. private label diaper exit. Organic sales rose 2.5% Y/Y, led by 2.4% volume growth in the quarter.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read:</em> <em><a href=\"https://www.benzinga.com/news/legal/25/08/47420402/kimberly-clark-to-pay-around-40-million-over-surgical-gown-designs\" rel=\"noreferrer noopener\" target=\"_blank\">Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs</a></em></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><p class=\"block core-block\">North American net sales decreased 0.8% Y/Y to $2.7 billion in the quarter, due to the exit of the company’s private label diaper business in the U.S.</p><!--/$--><!--$--><p class=\"block core-block\">Meanwhile, International Personal Care net sales increased 1.9% Y/Y to $1.4 billion, with organic sales growth of 2.1% Y/Y.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Bottom Line</h2><!--/$--><!--$--><p class=\"block core-block\">Adjusted gross margin was 36.8%, down 170 basis points from the prior year, owing to unfavorable pricing net of cost inflation and higher tariff-related costs.</p><!--/$--><!--$--><p class=\"block core-block\">Adjusted operating profit was $683 million, unchanged from last year, as efficiency gains and lower incentive accruals offset gross margin headwinds.</p><!--/$--><!--$--><p class=\"block core-block\">The net income of equity companies was $46 million, in line with million in the prior year.</p><!--/$--><!--$--><p class=\"block core-block\">Total debt was $7.3 billion as of September 30, down from $7.4 billion as of December 31, 2024.</p><!--/$--><!--$--><p class=\"block core-block\">Kimberly-Clark exited the quarter with cash and equivalents worth $617 million.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“The operating environment remains dynamic, but we continue to execute our strategy with discipline and excellence as we play to win,” said Kimberly-Clark Chairman and CEO <strong>Mike Hsu</strong>.</p><!--/$--><!--$--><p class=\"block core-block\">The company said its performance was driven by resilient consumer demand, pioneering product innovations, and sustained industry-leading productivity.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">For 2025, the company <a href=\"https://www.benzinga.com/calendars/guidance\" rel=\"noreferrer noopener\" target=\"_blank\">expects organic sales</a> to grow roughly in line with the weighted average growth of its categories and markets, currently around 2%.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Kimberly-Clark expects to face a ~100-basis-point headwind from currency translation and a ~290-basis-point impact from the PPE divestiture and U.S. private label diaper exit.</p><!--/$--><!--$--><p class=\"block core-block\">The company expects 2025 adjusted operating profit to grow at a low single-digit rate on a constant-currency basis, with a ~380-basis-point headwind from the PPE divestiture and U.S. private label diaper exit, and an additional ~70-basis-point impact from currency translation.</p><!--/$--><!--$--><p class=\"block core-block\">Kimberly-Clark projects adjusted EPS to grow at a low-to-mid single-digit rate on a constant-currency basis, including a ~320-basis-point headwind from the divestiture and diaper exit.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action: </strong>KMB shares were trading higher by 3.43% to $120.72 premarket at last check Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48525315\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/node/48446177\" rel=\"noreferrer noopener\" target=\"_blank\">P&amp;G Holds Its Premium As Analysts Cite Durable Growth Beyond Near-Term Tariff Hits</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by JHVEPhoto Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Irving--Texas--Usa---March-20--2022-Kimb.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48525315/kimberly-clark-proves-resilient-with-firm-sales-in-shifting-market",
            "pub_date": "2025-10-30 20:42:24",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69035eb9ecb8a70001457a27",
            "title": "BT, CrowdStrike Team Up To Bring AI Cybersecurity To UK Small Businesses",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Thursday, <strong>BT Group</strong> (OTC:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BTGOF\" target=\"_blank\">BTGOF</a>) announced it has partnered with <strong>CrowdStrike Holdings Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CRWD\" target=\"_blank\">CRWD</a>) to <a href=\"https://www.benzinga.com/pressreleases/25/10/b48519363/crowdstrike-and-bt-partner-to-transform-uk-smb-cybersecurity\" rel=\"noreferrer noopener\" target=\"_blank\">launch BT Business Antivirus Detect and Respond,</a> a cybersecurity service powered by CrowdStrike's Falcon Go platform.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em>CRWD is trading near recent highs. <a href=\"https://www.benzinga.com/quote/CRWD\" rel=\"noreferrer noopener\" target=\"_blank\">Check the market position here</a></em></strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The new offering targets small and medium-sized businesses (SMBs) in the United Kingdom, delivering AI-driven protection with ongoing support from BT's security experts.</p><!--/$--><!--$--><p class=\"block core-block\">Many SMBs remain vulnerable to cyberattacks due to limited resources and expertise, with only a small portion using AI-based defenses, according to CrowdStrike's State of SMB Cybersecurity Survey.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: </em></strong><em><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48498011/nvidia-stock-is-on-fire-heres-why-it-could-surge-30-more\" rel=\"noreferrer noopener\" target=\"_blank\">Nvidia Stock Is On Fire—Here's Why It Could Surge 30% More</a></em></p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">The service combines BT's 24/7 managed support with CrowdStrike's AI-native technology to help SMBs prevent ransomware and data breaches. It is designed for easy deployment, offering real-time threat detection and response without adding operational complexity.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Daniel Bernard</strong>, CrowdStrike's chief business officer, said the partnership aims to deliver \"AI-powered protection once reserved for the world's largest enterprises\" to UK SMBs, turning cybersecurity into \"a business advantage.\"</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Chris Sims</strong>, BT Business's chief commercial officer, said customers want simple, effective protection and that the collaboration brings \"world-class security without added complexity.\"</p><!--/$--><!--$--><p class=\"block core-block\">The initiative aligns with CrowdStrike's wider strategy to strengthen its AI ecosystem.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">On Wednesday, CrowdStrike's <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48476700/crowdstrike-stock-climbing-after-nvidia-partnership-announcement\" rel=\"noreferrer noopener\" target=\"_blank\">stock climbed </a>after the Nvidia partnership announcement highlighted the company's expanding role in AI-powered cybersecurity. I</p><!--/$--><!--$--><p class=\"block core-block\">ts alliance with BT reinforces its position as a leader in intelligent digital defense.</p><!--/$--><!--$--><p class=\"block core-block\">The collaboration enhances BT's cybersecurity portfolio while broadening CrowdStrike's European footprint.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">With cyber threats on the rise, the demand for cost-effective, AI-driven security continues to grow, benefiting both companies and investors focused on digital resilience.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>CRWD Price Action:</strong> CrowdStrike Holdings shares were down 0.45% at $543.05 during premarket trading on Thursday. The stock is trading near its 52-week high of $553.64, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48525527\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48521417/mastercard-in-late-stage-talks-to-acquire-crypto-startup-zerohash-report\" rel=\"noreferrer noopener\" target=\"_blank\">Mastercard In ‘Late-Stage Talks' To Acquire Crypto Startup Zerohash: Report</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by Bluestork via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/CrowdStrike-Holdings--Inc-.jpeg",
            "link": "https://www.benzinga.com/markets/tech/25/10/48525527/bt-crowdstrike-team-up-to-bring-ai-cybersecurity-to-uk-small-businesses",
            "pub_date": "2025-10-30 20:49:01",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69036373ecb8a70001457cd0",
            "title": "Advance Auto Parts CEO Sees Stronger Margins Ahead, Tightens Outlook",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Advance Auto Parts Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AAP\" target=\"_blank\">AAP</a>) stock rose Thursday after reporting its <a href=\"https://www.benzinga.com/pressreleases/25/10/b48521505/advance-auto-parts-reports-third-quarter-2025-results\" rel=\"noreferrer noopener\" target=\"_blank\">third-quarter</a> results.</p><!--/$--><!--$--><p class=\"block core-block\">The company posted adjusted earnings of 92 cents per share, reversing a loss of 5 cents a year earlier and <a href=\"https://www.benzinga.com/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">topping Wall Street’s forecast of 75 cents</a> for the third quarter.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company reported quarterly revenue of $2.04 billion, narrowly topping the $2.03 billion consensus estimate but down 5.2% from $2.15 billion a year earlier. Comparable store sales for the third quarter of 2025 rose 3%.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/08/47161130/advance-auto-parts-early-innings-of-3-year-turnaround-plan\" rel=\"noreferrer noopener\" target=\"_blank\">Advance Auto Parts Turnaround Plan Is ‘Progressing’ Despite Weak Guidance: Analyst</a></em></strong></p><!--/$--><!--$--><p class=\"block core-block\">Adjusted gross profit margin for the quarter improved to 44.8% from 42.3% a year ago, while adjusted operating income margin rose to 4.4% from 0.7%.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">During the forty weeks ended October 4, 2025, Advance Auto Parts opened 26 stores and closed 517, bringing its total store count to 4,297.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Capital Allocation</h2><!--/$--><!--$--><p class=\"block core-block\">The company declared a regular cash dividend of 25 cents per share to be paid on January 23, 2026, to all common stockholders of record as of January 9, 2026.</p><!--/$--><!--$--><p class=\"block core-block\">The company’s cash and cash equivalents totaled $3.17 billion as of October 4, 2025.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">AAP narrowed its full-year 2025 adjusted earnings per share guidance to $1.75-$1.85, up from a previous range of $1.20-$2.20, slightly above the $1.72 per share analyst <a href=\"https://www.benzinga.com/calendars/guidance\" rel=\"noreferrer noopener\" target=\"_blank\">estimate</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The company also raised its full-year sales forecast to $8.55 billion-$8.60 billion from $8.40 billion-$8.60 billion, compared with analysts’ consensus of $8.58 billion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company expects its adjusted operating income margin from continuing operations to range between 2.4% and 2.6%. Full-year 2025 guidance assumes that current tariffs will remain in effect through the end of the year.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">CEO Commentary</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Shane O’Kelly</strong>, president and chief executive officer, said, “We delivered our strongest quarterly performance in over two years, thanks to the team’s determination, commitment to our turnaround objectives, and their dedication to serving our customers. Our comparable sales performance was led by growth in the Pro channel. The DIY channel also delivered positive comparable sales growth in the quarter.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“We continue to make progress on our strategic priorities, and based on our updated guidance we are on track to deliver approximately 200 basis points of annual margin expansion in the first year of our turnaround. Our initiatives are geared toward delivering sustained, profitable growth and we remain committed to advancing our strategic priorities to create shareholder value over the long term.”</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: AAP shares were trading higher by 8.83% to $60.00 premarket at last check Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48526210\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48524289/jim-cramer-likes-toast-but-isnt-buying-shares-yet\" rel=\"noreferrer noopener\" target=\"_blank\">Jim Cramer Likes Toast, But Isn’t Buying Shares—Yet</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo by Ken Wolter via Shutterstock</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Burnsville--Mn---usa---March-4--2017-Adv.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48526210/advance-auto-parts-ceo-sees-stronger-margins-ahead-tightens-outlook",
            "pub_date": "2025-10-30 21:09:10",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}